US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
カナダ
TSX
Novo Resources Corp (NVO)
Novo Resources Corp (NVO) ニュース

NVO

Novo Resources (NVO)

Novo Resources Corp

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:NVO

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/08/29	01 : 14	PR Newswire (Canada)	Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NVO.WT	TSX:NVO	Novo Resources Corp
2023/08/29	01 : 10	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trading Halt - NVO.WT	TSX:NVO	Novo Resources Corp
2021/02/05	23 : 00	PR Newswire (Canada)	TMX Group Equity Financing Statistics - January 2021	TSX:NVO	Novo Resources Corp
2010/02/16	22 : 00	PR Newswire (US)	Novo Nordisk Makes Victoza(R) Commercially Available in the United States	NYSE:NVO
2010/01/22	05 : 49	PR Newswire (US)	Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'	NYSE:NVO
2010/01/14	17 : 01	PR Newswire (US)	Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates	NYSE:NVO
2010/01/13	23 : 43	PR Newswire (US)	/K I L L K I L L K I L L - National Changing Diabetes Program/	NYSE:NVO
2010/01/13	14 : 01	PR Newswire (US)	Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates	NYSE:NVO
2009/12/02	23 : 00	PR Newswire (US)	FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause	NYSE:NVO
2009/11/27	23 : 30	PR Newswire (US)	Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows	NYSE:NVO
2009/11/27	14 : 01	PR Newswire (US)	Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows	NYSE:NVO
2009/11/19	22 : 00	PR Newswire (US)	Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show	NYSE:NVO
2009/10/30	22 : 00	PR Newswire (US)	Novo Nordisk is Changing Possibilities in Hemophilia	NYSE:NVO
2009/10/20	21 : 30	PR Newswire (US)	Data Analysis Reinforces the Safety Profile of Levemir(R)	NYSE:NVO
2009/09/01	22 : 58	PR Newswire (US)	Research Supports Improving 'Scoring' of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary Decisio	NYSE:NVO
2009/09/01	21 : 00	PR Newswire (US)	National Changing Diabetes Program Supports Improvements in Health Cost Estimates	NYSE:NVO
2009/08/27	22 : 03	PR Newswire (US)	Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families	NYSE:NVO
2009/08/12	23 : 00	PR Newswire (US)	Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes	NYSE:NVO
2009/08/10	22 : 00	PR Newswire (US)	Photos: Norditropin NordiFlex(R) 30 mg/3 mL Prefilled Pen Offers Children Needing a Larger Dose of Growth Hormone a Convenient O	NYSE:NVO
2009/08/05	21 : 30	PR Newswire (US)	Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North America	NYSE:NVO
2009/07/23	22 : 00	PR Newswire (US)	NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care	NYSE:NVO
2009/07/16	02 : 43	PR Newswire (US)	FDA Approves NovoLog(R) Labeling Update	NYSE:NVO
2009/07/14	02 : 51	PR Newswire (US)	Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and Treatment	NYSE:NVO
2009/06/29	04 : 18	PR Newswire (US)	Novo Nordisk Insulin Analogs Have Proven Safety Profiles	NYSE:NVO
2009/06/14	02 : 09	PR Newswire (US)	Novo Nordisk Warns Customers About Stolen Insulin	NYSE:NVO
2009/06/12	23 : 25	PR Newswire (US)	Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit	NYSE:NVO
2009/06/09	06 : 50	PR Newswire (US)	The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide	NYSE:NVO
2009/06/08	21 : 00	PR Newswire (US)	Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride	NYSE:NVO
2009/06/07	23 : 00	PR Newswire (US)	Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162	NYSE:NVO
2009/05/21	02 : 21	PR Newswire (US)	Americans Who Don't Know They Have Diabetes Incur $18 Billion in Health Expenses Each Year	NYSE:NVO

Showing the most relevant articles for your search:TSX:NVO

1 2 3 4 5 6 次へ >>

Gold vs US Dollar

Deutsche Telekom (QX)

Health Care Select Sector

Invesco QQQ Trust Series 1

Bank of America

US Dollar vs Yen

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約